USANA HEALTH SCIENCES, INC. (USNA) Current Ratio
- Current ratio · latest quarter: Value 2.66×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-07-04; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.66× | Current assets / current liabilities. $281.07M ÷ $105.67M ≈ 2.66× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 281.07M USD | Assets, Current |
| Current obligations | 105.67M USD | Liabilities, Current |
| Cash and equivalents | 168.56M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | 86.34M USD | Inventory, Net |
| Payables | 15.43M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-04 | $281.07M | $105.67M | $168.56M | (m) | (m) | $86.34M | $15.43M | (m) | 2.66× |
| 2026-04-04 | $294.23M | $117.24M | $162.75M | (m) | (m) | $96.36M | $16.23M | (m) | 2.51× |
| 2026-01-03 | $288.40M | $128.56M | $158.38M | (m) | (m) | $102.61M | $17.26M | (m) | 2.24× |
| 2025-09-27 | $264.06M | $118.66M | $145.35M | (m) | (m) | $90.78M | $16.22M | (m) | 2.23× |
| 2025-06-28 | $261.87M | $121.63M | $151.34M | (m) | (m) | $83.27M | $17.90M | (m) | 2.15× |
| 2025-03-29 | $281.39M | $137.38M | $179.61M | (m) | (m) | $73.56M | $13.97M | (m) | 2.05× |
| 2024-12-28 | $279.19M | $139.63M | $181.77M | (m) | (m) | $69.73M | $11.98M | (m) | 2.00× |
| 2024-09-28 | $451.19M | $114.78M | $364.89M | (m) | (m) | $63.98M | $7.04M | (m) | 3.93× |
| 2024-06-29 | $419.08M | $103.90M | $332.42M | (m) | (m) | $61.83M | $6.65M | (m) | 4.03× |
| 2024-03-30 | $421.07M | $112.63M | $328.34M | (m) | (m) | $60.87M | $8.27M | (m) | 3.74× |
| 2023-12-30 | $417.75M | $118.84M | $330.42M | (m) | (m) | $61.45M | $10.07M | (m) | 3.52× |
| 2023-09-30 | $390.46M | $112.56M | $307.08M | (m) | (m) | $60.08M | $9.32M | (m) | 3.47× |
| 2023-07-01 | $387.65M | $113.84M | $300.18M | (m) | (m) | $61.96M | $9.27M | (m) | 3.41× |
| 2023-04-01 | $395.88M | $130.22M | $295.45M | (m) | (m) | $64.49M | $10.51M | (m) | 3.04× |
| 2022-12-31 | $384.38M | $143.83M | $288.42M | (m) | (m) | $67.09M | $11.05M | (m) | 2.67× |
| 2022-10-01 | $341.15M | $125.85M | $246.88M | (m) | (m) | $67.28M | $10.36M | (m) | 2.71× |
| 2022-07-02 | $342.00M | $133.59M | $230.37M | (m) | (m) | $84.16M | $10.18M | (m) | 2.56× |
| 2022-04-02 | $363.79M | $157.97M | $237.75M | (m) | (m) | $97.58M | $11.25M | (m) | 2.30× |
| 2022-01-01 | $365.12M | $160.79M | $239.83M | (m) | (m) | $98.32M | $13.51M | (m) | 2.27× |
| 2021-10-02 | $368.43M | $157.96M | $248.69M | (m) | (m) | $96.32M | $13.71M | (m) | 2.33× |
| 2021-07-03 | $381.51M | $153.00M | $265.37M | (m) | (m) | $89.59M | $13.14M | (m) | 2.49× |
| 2021-04-03 | $373.18M | $151.45M | $256.96M | (m) | (m) | $87.65M | $11.95M | (m) | 2.46× |
| 2021-01-02 | $425.29M | $168.07M | $311.92M | (m) | (m) | $90.22M | $18.20M | (m) | 2.53× |
| 2020-09-26 | $386.03M | $160.86M | $278.42M | (m) | (m) | $78.17M | $14.17M | (m) | 2.40× |
| 2020-06-27 | $324.95M | $139.72M | $227.37M | (m) | (m) | $69.28M | $10.94M | (m) | 2.33× |
| 2020-03-28 | $286.76M | $124.50M | $194.10M | (m) | (m) | $60.57M | $11.82M | (m) | 2.30× |
| 2019-12-28 | $329.28M | $136.10M | $234.83M | (m) | (m) | $68.91M | $12.53M | (m) | 2.42× |
| 2019-09-28 | $282.98M | $129.65M | $182.75M | (m) | (m) | $76.14M | $8.61M | (m) | 2.18× |
| 2019-06-29 | $348.78M | $128.76M | $231.35M | (m) | (m) | $88.13M | $11.69M | (m) | 2.71× |
| 2019-03-30 | $370.18M | $129.99M | $225.04M | (m) | (m) | $86.47M | $11.70M | (m) | 2.85× |
| 2018-12-29 | $392.33M | $148.69M | $214.33M | (m) | (m) | $81.95M | $9.95M | (m) | 2.64× |
| 2018-09-29 | $434.76M | $152.89M | $239.75M | (m) | (m) | $81.11M | $14.47M | (m) | 2.84× |
| 2018-06-30 | $404.66M | $136.75M | $256.33M | (m) | (m) | $74.12M | $12.38M | (m) | 2.96× |
| 2018-03-31 | $366.13M | $126.37M | $266.20M | (m) | (m) | $68.13M | $12.68M | (m) | 2.90× |
| 2017-12-30 | $340.16M | $141.18M | $247.13M | (m) | (m) | $62.92M | $11.79M | (m) | 2.41× |
| 2017-09-30 | $286.45M | $121.43M | $191.75M | (m) | (m) | $63.33M | $9.29M | (m) | 2.36× |
| 2017-07-01 | $330.16M | $135.37M | $229.37M | (m) | (m) | $68.69M | $7.44M | (m) | 2.44× |
| 2017-04-01 | $279.16M | $110.86M | $176.32M | (m) | (m) | $69.68M | $8.84M | (m) | 2.52× |
| 2016-12-31 | $277.86M | $138.49M | $175.77M | (m) | (m) | $64.81M | $9.04M | (m) | 2.01× |
| 2016-10-01 | $248.11M | $128.43M | $134.54M | (m) | (m) | $74.15M | $10.59M | (m) | 1.93× |
| 2016-07-02 | $221.86M | $127.98M | $112.40M | (m) | (m) | $71.33M | $10.08M | (m) | 1.73× |
| 2016-04-02 | $243.40M | $112.75M | $150.50M | (m) | (m) | $67.55M | $7.99M | (m) | 2.16× |
| 2016-01-02 | $244.26M | $131.41M | $143.21M | (m) | (m) | $66.12M | $10.04M | (m) | 1.86× |
| 2015-10-03 | $269.82M | $114.47M | $174.19M | (m) | (m) | $61.58M | $9.50M | (m) | 2.36× |
| 2015-07-04 | $244.81M | $112.86M | $150.93M | (m) | (m) | $54.02M | $9.04M | (m) | 2.17× |
| 2015-04-04 | $211.47M | $110.35M | $128.57M | (m) | (m) | $50.96M | $9.47M | (m) | 1.92× |
| 2015-01-03 | $190.93M | $108.70M | $111.13M | (m) | (m) | $45.25M | $7.78M | (m) | 1.76× |
| 2014-09-27 | $162.51M | $105.46M | $87.74M | (m) | (m) | $42.58M | $6.55M | (m) | 1.54× |
| 2014-06-28 | $201.93M | $88.70M | $118.27M | (m) | (m) | $44.53M | $6.41M | (m) | 2.28× |
| 2014-03-29 | $226.36M | $79.94M | $142.73M | (m) | (m) | $46.89M | $6.08M | (m) | 2.83× |
| 2013-12-28 | $229.04M | $95.87M | $137.34M | (m) | (m) | $47.24M | $9.50M | (m) | 2.39× |
| 2013-09-28 | $196.13M | $82.53M | $115.35M | (m) | (m) | $45.67M | $8.06M | (m) | 2.38× |
| 2013-06-29 | $166.02M | $74.61M | $96.06M | (m) | (m) | $41.71M | $7.29M | (m) | 2.23× |
| 2013-03-30 | $133.65M | $70.05M | $71.05M | (m) | (m) | $42.97M | $8.15M | (m) | 1.91× |
| 2012-12-29 | $132.54M | $70.84M | $70.84M | (m) | (m) | $36.48M | $7.04M | (m) | 1.87× |
| 2012-09-29 | $138.65M | $66.79M | $76.60M | (m) | (m) | $33.30M | $6.91M | (m) | 2.08× |
| 2012-06-30 | $123.51M | $66.75M | $65.54M | (m) | (m) | $33.80M | $6.41M | (m) | 1.85× |
| 2012-03-31 | $125.33M | $62.39M | $71.16M | (m) | (m) | $35.29M | $7.57M | (m) | 2.01× |
| 2011-12-31 | $106.06M | $59.70M | $50.35M | (m) | (m) | $36.97M | $7.95M | (m) | 1.78× |
| 2011-10-01 | $89.98M | $59.29M | $36.32M | (m) | (m) | $36.20M | $9.10M | (m) | 1.52× |
| 2011-07-02 | $79.26M | $54.49M | $24.94M | (m) | (m) | $35.38M | $8.35M | (m) | 1.45× |
| 2011-01-01 | $81.68M | $59.03M | $24.22M | (m) | (m) | $34.08M | $6.45M | (m) | 1.38× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |